Julie-Aurore Losman, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Purpura Fulminans | 2 | 2024 | 22 | 1.610 |
Why?
|
| Glutarates | 5 | 2023 | 236 | 1.180 |
Why?
|
| Isocitrate Dehydrogenase | 6 | 2023 | 871 | 0.890 |
Why?
|
| Dioxygenases | 2 | 2020 | 316 | 0.740 |
Why?
|
| Ketoglutaric Acids | 1 | 2020 | 78 | 0.740 |
Why?
|
| Leukemia | 3 | 2022 | 1511 | 0.690 |
Why?
|
| Protein C | 1 | 2018 | 138 | 0.640 |
Why?
|
| Thrombomodulin | 1 | 2018 | 102 | 0.630 |
Why?
|
| Perforin | 1 | 2018 | 168 | 0.630 |
Why?
|
| Molecular Targeted Therapy | 3 | 2018 | 2727 | 0.600 |
Why?
|
| Procollagen-Proline Dioxygenase | 2 | 2013 | 86 | 0.540 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2018 | 260 | 0.500 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2023 | 2942 | 0.440 |
Why?
|
| Myeloproliferative Disorders | 2 | 2017 | 606 | 0.400 |
Why?
|
| Glioma | 3 | 2023 | 3401 | 0.400 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2023 | 3523 | 0.360 |
Why?
|
| Sepsis | 1 | 2024 | 2593 | 0.350 |
Why?
|
| Histone Demethylases | 2 | 2023 | 321 | 0.230 |
Why?
|
| Hematopoiesis | 1 | 2013 | 2072 | 0.230 |
Why?
|
| Receptors, Complement | 1 | 2024 | 264 | 0.230 |
Why?
|
| Butyrate Response Factor 1 | 1 | 2022 | 10 | 0.220 |
Why?
|
| Mutation | 6 | 2023 | 29786 | 0.200 |
Why?
|
| Oncogenes | 3 | 2017 | 1265 | 0.190 |
Why?
|
| Citric Acid Cycle | 1 | 2020 | 232 | 0.170 |
Why?
|
| Capnocytophaga | 1 | 2018 | 26 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 15519 | 0.170 |
Why?
|
| Receptors, Interleukin-4 | 1 | 1999 | 65 | 0.170 |
Why?
|
| Signal Transduction | 5 | 2017 | 23403 | 0.160 |
Why?
|
| Neoplasms | 2 | 2020 | 21683 | 0.160 |
Why?
|
| Cell Hypoxia | 1 | 2020 | 675 | 0.160 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2019 | 167 | 0.150 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2022 | 388 | 0.150 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 13695 | 0.150 |
Why?
|
| Histone Code | 1 | 2018 | 163 | 0.150 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2018 | 182 | 0.140 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 627 | 0.140 |
Why?
|
| E-Selectin | 1 | 2018 | 579 | 0.140 |
Why?
|
| Interleukin-4 | 2 | 2002 | 1147 | 0.140 |
Why?
|
| Endothelium | 1 | 2018 | 778 | 0.140 |
Why?
|
| Calreticulin | 1 | 2016 | 98 | 0.130 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 954 | 0.130 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2017 | 434 | 0.130 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2016 | 157 | 0.120 |
Why?
|
| Repressor Proteins | 3 | 2022 | 3023 | 0.120 |
Why?
|
| Retinoblastoma Protein | 1 | 2018 | 704 | 0.120 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 1791 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 474 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 2077 | 0.110 |
Why?
|
| Histones | 1 | 2023 | 2599 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2002 | 2915 | 0.100 |
Why?
|
| Enzyme Inhibitors | 2 | 2022 | 3798 | 0.100 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 1782 | 0.100 |
Why?
|
| Catalysis | 1 | 2013 | 761 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 20822 | 0.100 |
Why?
|
| DNA Damage | 1 | 2020 | 2432 | 0.090 |
Why?
|
| Alleles | 2 | 2018 | 6933 | 0.090 |
Why?
|
| Pituitary Neoplasms | 1 | 2018 | 1345 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2023 | 4286 | 0.080 |
Why?
|
| Humans | 16 | 2024 | 744343 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 4149 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 3703 | 0.070 |
Why?
|
| Neurodegenerative Diseases | 1 | 2014 | 1061 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2018 | 2282 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2017 | 5535 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2018 | 4599 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 16689 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 2 | 2002 | 34 | 0.060 |
Why?
|
| Salicylanilides | 1 | 2022 | 15 | 0.060 |
Why?
|
| STAT6 Transcription Factor | 2 | 2002 | 199 | 0.050 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2002 | 175 | 0.050 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 1912 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11483 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 8863 | 0.050 |
Why?
|
| Models, Biological | 2 | 2013 | 9583 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 9648 | 0.050 |
Why?
|
| Disease Progression | 1 | 2017 | 13284 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2024 | 53288 | 0.040 |
Why?
|
| Oncogene Proteins v-abl | 1 | 1998 | 22 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2018 | 3701 | 0.040 |
Why?
|
| Cell Line | 5 | 2016 | 15997 | 0.040 |
Why?
|
| Pyrimidines | 2 | 2022 | 2942 | 0.040 |
Why?
|
| HL-60 Cells | 1 | 2019 | 365 | 0.040 |
Why?
|
| Animals | 9 | 2022 | 168757 | 0.040 |
Why?
|
| Genes, Retinoblastoma | 1 | 2018 | 136 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 13102 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2002 | 4554 | 0.040 |
Why?
|
| Phosphotransferases | 1 | 1999 | 308 | 0.040 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2019 | 236 | 0.040 |
Why?
|
| Interleukin-3 | 1 | 1998 | 444 | 0.040 |
Why?
|
| Heart Septal Defects | 1 | 2018 | 192 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 2002 | 5021 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 5853 | 0.040 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1999 | 431 | 0.040 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 1999 | 563 | 0.040 |
Why?
|
| Triazoles | 1 | 2022 | 911 | 0.040 |
Why?
|
| Structure Collapse | 1 | 2016 | 4 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11524 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1999 | 1454 | 0.030 |
Why?
|
| Mice | 7 | 2022 | 81183 | 0.030 |
Why?
|
| Integrases | 1 | 2018 | 533 | 0.030 |
Why?
|
| STAT Transcription Factors | 1 | 2016 | 182 | 0.030 |
Why?
|
| Janus Kinases | 1 | 2016 | 244 | 0.030 |
Why?
|
| Transgenes | 1 | 2018 | 1009 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 1878 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 2016 | 399 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2019 | 2716 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2018 | 981 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2018 | 3772 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2019 | 1420 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 1903 | 0.030 |
Why?
|
| Trans-Activators | 2 | 2002 | 2924 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2018 | 63114 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2014 | 3689 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2012 | 198 | 0.020 |
Why?
|
| Protein Binding | 3 | 2016 | 9386 | 0.020 |
Why?
|
| Cell Division | 1 | 1998 | 4568 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1999 | 2440 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1998 | 2455 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2016 | 2765 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2018 | 4161 | 0.020 |
Why?
|
| Echocardiography | 1 | 2018 | 5102 | 0.020 |
Why?
|
| Female | 3 | 2019 | 380194 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 6386 | 0.020 |
Why?
|
| Base Sequence | 1 | 2016 | 12797 | 0.020 |
Why?
|
| Middle Aged | 1 | 2018 | 213383 | 0.020 |
Why?
|
| Adult | 1 | 2018 | 214055 | 0.020 |
Why?
|
| Astrocytes | 1 | 2012 | 1270 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 3386 | 0.010 |
Why?
|
| Apoptosis | 1 | 2019 | 9727 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2022 | 12208 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 3617 | 0.010 |
Why?
|
| Transfection | 2 | 2002 | 5892 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 829 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 464 | 0.010 |
Why?
|
| Male | 1 | 2018 | 350118 | 0.010 |
Why?
|
| Heart | 1 | 2014 | 4467 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 21827 | 0.010 |
Why?
|
| Luciferases | 1 | 2002 | 733 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2002 | 595 | 0.010 |
Why?
|
| Gene Library | 1 | 2002 | 1074 | 0.010 |
Why?
|
| Janus Kinase 1 | 1 | 1998 | 104 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 2050 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16365 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 9438 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 18029 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2002 | 1267 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 2307 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 4320 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2012 | 10481 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1998 | 1276 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1998 | 1783 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 8436 | 0.010 |
Why?
|
| Binding Sites | 1 | 1998 | 6114 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2002 | 13033 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 1998 | 12072 | 0.000 |
Why?
|
| Time Factors | 1 | 2002 | 40075 | 0.000 |
Why?
|